对乙酰氨基酚干扰Nova StatStrip®血糖仪:一例病例报告及台面验证
本文报告一例25岁女性因对乙酰氨基酚与苯海拉明复方制剂过量就诊,患者反应极低,使用Nova StatStrip®血糖仪行床旁血糖检测,连续尝试5台不同仪器均显示错误信息。实验室Beckman Coulter® Unicel DxC 800检测显示血糖180 mg/dL、对乙酰氨基酚浓度465 mg/L。台面实验将血清加入不同浓度对乙酰氨基酚后,Nova StatStrip®血糖仪在浓度399 mg/L及以上出现干扰。作者结论为极高浓度对乙酰氨基酚可干扰床旁血糖仪,即使既往报告稳健的Nova StatStrip®血糖仪也不例外,临床医生处理对乙酰氨基酚过量时应知晓此可能干扰。
要点
- 25岁女性对乙酰氨基酚与苯海拉明复方制剂过量后反应极低,Nova StatStrip®血糖仪连续5台均显示错误信息。
- 实验室检测该患者血糖180 mg/dL、对乙酰氨基酚浓度465 mg/L。
- 台面实验显示血清对乙酰氨基酚浓度399 mg/L及以上时Nova StatStrip®血糖仪出现干扰。
- 作者结论:极高浓度对乙酰氨基酚可干扰床旁血糖仪,包括既往报告稳健的Nova StatStrip®血糖仪。
- 临床医生处理对乙酰氨基酚过量患者时应知晓此可能干扰。
适用人群与场景
- 对乙酰氨基酚过量患者,尤其是因反应极低需床旁血糖评估者。
诊断标准与关键阈值
- 台面实验:血清对乙酰氨基酚浓度399 mg/L及以上时Nova StatStrip®血糖仪出现干扰。
红旗征与不能漏的情况
- 对乙酰氨基酚过量患者使用Nova StatStrip®血糖仪检测时连续多台仪器显示错误信息,应警惕对乙酰氨基酚干扰可能。
研究设计与关键结果
- 病例报告:25岁女性因对乙酰氨基酚与苯海拉明复方制剂过量就诊,反应极低,Nova StatStrip®血糖仪连续5台均显示错误信息;实验室Beckman Coulter® Unicel DxC 800检测血糖180 mg/dL、对乙酰氨基酚浓度465 mg/L。
- 台面实验:血清加入不同浓度对乙酰氨基酚后,Nova StatStrip®血糖仪在浓度399 mg/L及以上出现干扰。
证据类型、等级与局限
- 证据类型:病例报告及台面验证实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:极高浓度对乙酰氨基酚可干扰床旁血糖仪,即使既往报告稳健的Nova StatStrip®血糖仪也不例外;临床医生处理对乙酰氨基酚过量患者时应知晓此可能干扰。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Context: Point-of-care glucose meters are an integral part in the assessment of patients with altered mental status. For this reason, glucose meters are checked for interference from commonly encountered substances, including acetaminophen. The Nova StatStrip® glucose meter has previously been reported to be resistant to interference. We report a case of a very high acetaminophen concentration causing interference with this point-of-care glucose meter.Case report: A 25-year-old female presented after an overdose of acetaminophen and diphenhydramine combination product. Patient was minimally responsive, so a point-of-care glucose check was attempted using the Nova StatStrip® glucose meter. Five different meters were attempted, and each showed an error message. Laboratory analysis using Beckman Coulter® Unicel DxC 800 revealed a glucose of 180 mg/dL and an acetaminophen concentration of 465 mg/L. Serum spiked with acetaminophen at different concentrations revealed interference with the Nova StatStrip® glucose meter at a concentration of 399 mg/L and above. To our knowledge, this interference with the Nova StatStrip® glucose meter has not been reported in the medical literature.Conclusion: Very high levels of acetaminophen can interfere with point-of-care glucose meters, even those that have previously been reported to be robust such as the Nova StatStrip® glucose meter. Clinicians should be aware of this possible interference when treating patients with acetaminophen overdose.
参考来源
- Chenoweth JA, Dang LT, Gao G, et al. Acetaminophen interference with Nova StatStrip® Glucose Meter: case report with bench top confirmation. Clin Toxicol (Phila). 2020. PMID: 32141341. doi:10.1080/15563650.2020.1732404
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。